Home/Nascent Biotech/Dr. Ivan Babic
DI

Dr. Ivan Babic

Science Advisory Board, Director of Research and Development

Nascent Biotech

Therapeutic Areas

Nascent Biotech Pipeline

DrugIndicationPhase
Pritumumab (PTB)Gliomas (Brain Tumors)Phase II
Pritumumab-based ADCUndisclosed CancersDiscovery